Prophylaxis of osteoporosis with calcium, estrogens and/or eelcatonin: Comparative longitudinal study of bone mass

Maturitas

Volumn 23, Issue 3, 1996, Pages 327-332

  Perez Jaraiz M D ^a   Revilla, M ^a   Alvarez De Los Heros, J I ^a   Villa, L F ^a   Rico, H ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Bone densitometry; Calcium; Eel calcitonin; Hormone replacement treatment; Postmenopausal bone loss; Prophylaxis of osteoporosis

Indexed keywords

CALCITONIN; CALCIUM; ESTRADIOL; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; BONE DENSITY; BONE MASS; DENSITOMETRY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; SEASONAL VARIATION; TRANSDERMAL DRUG ADMINISTRATION;

ANGUILLIFORMES;

EID: 0343774143     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(96)00999-1     Document Type: Article

References (36)

1. Lindsay R, Hart DM, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomized women. Lancet 1980; ii: 1151-1153.
2. Ettinger B, Gennat MK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med 1987; 106: 40-45.
3. Reginster JY, Albert A, Lecart MP et al. One-year controlled randomized trial of prevention of early post-menopausal bone loss by intranasal calcitonin. Lancet 1987; ii: 1481-1483.
4. Riis B, Nilas L, Christiansen C. Does calcium potentiate the effect of estrogen therapy on postmenopausal bone loss? Bone Miner 1987; 2: 1-9.
5. Riis BJ, Thomsen K, Strom V, Christiansen C. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol 1987; 156: 61-65.
6. Rico H, Revilla M, Villa LF, Alvarez de Buergo M, Ruiz-Contreras D. Determinants of total and regional bone mineral content and density in postpubertal normal women. Metabolism 1994; 43: 263-266.
7. Compston JE, Laskey MA, Croucher PI, Coxon A, Kreitzman S. Effect of diet-induced weight loss on total body bone mass. Clin Sci 1992; 82: 429-432.
8. Nishizawa V, Koyama H, Shoji T, et al. Altered calcium homeostasis accompanying changes of regional bone mineral during a very-low-calorie diet. Am J Clin Nutr 1992; 56: S265-S267.
9. Harris S, Dallai GE, Dawson-Hughes B. Influence of body weight on rates of change in bone density of the spine, hip, and radius in postmenopausal women. Calcif Tissue Int 1992; 50: 19-23.
10. Dawson-Hughes B, Harris S. Thiazides and seasonal bone change in healthy postmenopausal women. Bone Miner 1993; 21: 41-51.
11. Rico H, Revilla M, Cardenas JL, et al. Influence of weight and seasonal changes on radiogrammetry and bone densitometry. Calcif Tissue Int 1994; 54: 385-388.
12. Rico H, Revilla M. Factors affecting bone mass. J Am Med Assoc 1994; 272: 1003.
13. Rico H, Revilla M. Bone mass, body weight, and seasonal bone changes. Calcif Tissue Int 1994; 54: 523-524.
14. Gordan GS. Prevention of bone loss and fracture in women. Maturitas 1984; 6: 225-242.
15. Rico H. Prevention of postmenopausal osteoporosis. In: Nordin BEC, ed. Osteoporosis contributions to modern management. Lancaster: Parthenon, 1990; 39-46.
16. Rico H, Hernandez ER, Revilla M, Villa LF, Alvarez de Buergo M, Cuende E. Bone changes in postmenopausal Spanish women. Calcif Tissue Int 1993; 52: 103-106.
17. Rico H, Villa LF. Serum tartrate-resistant acid phosphatase as a biochemical marker of bone remodelling. Calcif Tissue Int 1993; 52: 149-150.
18. Delmas PD. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol Metab Clin North Am 1990; 19: 1-18.
19. Janckila AJ, Woodford TA, Lam KW, Li CV, Tam LT. Protein-tyrosine phosphatase activity of hairy cell tartrate-resistant acid phosphatase. Leukemia 1992; 6: 199-203.
20. Catovsky D. Chronic lymphoid leukemias. In: Hoffbrand AV, Lewis SM, eds. Postgraduate haematology, 3rd ed. Oxford: Heinemann, 1989; 418-450.
21. Lees B, Stevenson JC. An evaluation of dual-energy X-ray absorptiometry and comparison with dual-photon absorptiometry. Osteoporosis Int 1992; 2: 146-152.
22. Field CS, Ory SJ, Wahner HW, Herrmann RR, Judd HL, Riggs BL. Preventive effects of transdermal 17beta-estradiol on osteoporotic changes after surgical menopause - a 2-year placebo-controlled trial. Am J Obstet Gynecol 1993; 168: 114-121.
23. Reginster JY, Christiansen C, Dequinze B et al. Effect of transdermal 17-beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone résorption in natural menopause. Calcif Tissue Int 1993; 53: 13-16.
24. Rico H, Cabranes JA, Hernandez ER, Perez del Molino J, Escudero G. Effect of calcium pidolate on biochemical and hormonal parameters in involutional osteoporosis. Maturitas 1990; 12: 105-111.
25. Horowitz M, Need AG, Philcox JC, Nordin BEC. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women. Horm Metab Res 1985; 17: 311-312.
26. Horowitz M, Need AG, Philcox JC, Nordin BEC. Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women. Am J Clin Nutr 1984; 39: 857-859.
27. Woo J, Swaminathan R, Lau E, MacDonald D, Pang CP, Nordin BEC. Biochemical effects of a single oral dose of calcium on bone metabolism in elderly Chinese women. Calcif Tissue Int 1991; 48: 157-160.
28. Fuleihan GE, Brown EM, Curtis K et al. Effect of sequential and daily continuous hormone replacement therapy on indexes of mineral metabolism. Arch Intern Med 1992; 152: 1904-1909.
29. Selby PL, Peacock M, Barkworth SA, Brown WB, Taylor G. Early effects of ethinyestradiol and norethisterone treatment in postmenopausal women on bone resorption and calcium regulating hormones. Clin Sci 1985; 69: 265-271.
30. Thomsen K, Riis BJ, Christiansen C, Rodbro P. Bone turnover in postmenopausal women after withdrawal of estrogen/gestagen replacement therapy. Gynecol Endocrinol 1987; 1: 169-175.
31. Adami S, Suppi R, Bertoldo F et al. Transdermal estradiol in the treatment of postmenopausal bone loss. Bone Miner 1989; 7: 79-86.
32. Stevenson JC, Cust MP, Gangar KF, Hillard TC, Lees B, Whitehead MI. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet 1990; 336: 265-269.
33. Maclntyre I, Whitehead MI, Banks LM, Stevenson JC, Wimalawansa SJ, Healey MJR. Calcitonin for prevention of postmenopausal bone loss. Lancet 1988; i: 900-902.
34. Polatti F, Perotti F, Angelini GP, Vassellatti D, Rapisardi I. Effects of salmon calcitonin suppositories in the prevention of bone loss in oophorectomized women. Maturitas 1993; 18: 73-76.
35. Avioli LV. The calcium controversy and the recommended dietary allowance. In: Avioli LV, ed. The osteoporotic syndrome, 2nd ed. Orlando: Grune and Stratton, 1987; 57-66.
36. Cummings RG. Calcium intake and bone mass: a quantitative review of the evidence. Calcif Tissue Int 1990; 47: 194-201. 1